W911QY13C0010
Definitive Contract
Overview
Government Description
Medical Countermeasures Advanced Development And Manufacturing (MCM ADM) Capability
Awardee
Awarding Agency
Funding Agency
Place of Performance
Alachua, FL 32615 United States
Pricing
Cost Plus Fixed Fee
Set Aside
None
Extent Competed
Full And Open Competition
Est. Average FTE
215
Related Opportunity
Analysis Notes
COVID-19 $4,361,774 (2%) percent of this Definitive Contract was funded by COVID-19 emergency acts including the CARES Act.
Amendment Since initial award the Potential End Date has been extended from 03/19/23 to 10/31/23.
Unrealized Backlog This Definitive Contract is complete with $5,466,762 of funded backlog and $89,466,386 of unfunded backlog unused, which is typically due to unexercised options.
Amendment Since initial award the Potential End Date has been extended from 03/19/23 to 10/31/23.
Unrealized Backlog This Definitive Contract is complete with $5,466,762 of funded backlog and $89,466,386 of unfunded backlog unused, which is typically due to unexercised options.
Resilience Government Services was awarded
Definitive Contract W911QY13C0010 (W911QY-13-C-0010)
for Medical Countermeasures Advanced Development And Manufacturing (MCM ADM) Capability
worth up to $366,290,602
by Joint PEO for Chemical, Biological, Radiological and Nuclear Defense
in March 2013.
The contract
has a duration of 10 years 7 months and
was awarded
through solicitation Medical Countermeasure Manufacturing Advanced Development Manufacturing (MCM ADM) Capability
full & open
with
NAICS 325412 and
PSC AE37
via direct negotiation acquisition procedures with 2 bids received.
As of today, the Definitive Contract has a total reported backlog of $89,466,386 and funded backlog of $5,466,762, though the contract is closed, so backlog may not be realized.
DOD Announcements
Sep 2014:
Nanotherapeutics, Inc.,* Alachua, Florida was awarded a $9,647,917 modification (P00018 ) to contract W911QY-13-C-0010 for Medical Countermeasures (MCM) Advanced Development and Manufacturing (ADM) capability for rapid development of countermeasures against chemical, biological, radiological, and nuclear attacks and outbreaks of naturally occurring and genetically engineered infectious diseases. Fiscal 2014 research, development, testing, and evaluation funds in the amount of $9,647,917were obligated at the time of the award. Estimated completion date is March 19, 2015. Work will be performed in Alachua, Florida. Army
Contracting Command, Natick, Massachusetts is the contracting activity. (Awarded Sept. 28, 2014).
May 2015: Nanotherapeutics Inc.,* Alachua, Florida, was awarded a $43,249,906 modification (P00020) to contract W911QY-13-C-0010 for research and development of medical countermeasures and their manufacture to counter a chemical, biological, radiological, nuclear and explosives attack against military and civilian targets. Work will be performed in Alachua, Florida, with an estimated completion date of Aug. 15, 2016. Fiscal 2014 research, development, testing, and evaluation funds in the amount of $4,324,906 were obligated at the time of the award. Army Contracting Command, Natick, Massachusetts, is the contracting activity.
Sep 2019: Ology Bioservices Inc.,* Alachua, Florida, was awarded a $10,870,944 modification (P00054) to contract W911QY-13-C-0010 to establish, commission and support an agile and flexible advanced development and manufacturing capability. Work will be performed in Alachua, Florida, with an estimated completion date of March 19, 2023. Fiscal 2020 research, development, test and evaluation funds in the amount of $7,845,964 were obligated at the time of the award. U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity.
Dec 2019: Ology Bioservices Inc., Alachua, Florida, was awarded an $8,553,208 modification (P00058) to contract W911QY-13-C-0010 to support the Medical Countermeasures Advanced Development and Manufacturing Center Sustainment by maintaining the Advanced Development and Manufacturing facility in a state of readiness and operational availability to develop, test and/or manufacture medical countermeasures. Work will be performed in Alachua, Florida, with an estimated completion date of March 19, 2023. Fiscal 2021 research, development, test and evaluation, defense-wide funds in the amount of $8,553,208 were obligated at the time of the award. U.S. Army Contracting Command, Aberdeen Proving Ground, Natick Division, Natick, Massachusetts, is the contracting activity.
Nanotherapeutics, Inc.,* Alachua, Florida was awarded a $9,647,917 modification (P00018 ) to contract W911QY-13-C-0010 for Medical Countermeasures (MCM) Advanced Development and Manufacturing (ADM) capability for rapid development of countermeasures against chemical, biological, radiological, and nuclear attacks and outbreaks of naturally occurring and genetically engineered infectious diseases. Fiscal 2014 research, development, testing, and evaluation funds in the amount of $9,647,917were obligated at the time of the award. Estimated completion date is March 19, 2015. Work will be performed in Alachua, Florida. Army
Contracting Command, Natick, Massachusetts is the contracting activity. (Awarded Sept. 28, 2014).
May 2015: Nanotherapeutics Inc.,* Alachua, Florida, was awarded a $43,249,906 modification (P00020) to contract W911QY-13-C-0010 for research and development of medical countermeasures and their manufacture to counter a chemical, biological, radiological, nuclear and explosives attack against military and civilian targets. Work will be performed in Alachua, Florida, with an estimated completion date of Aug. 15, 2016. Fiscal 2014 research, development, testing, and evaluation funds in the amount of $4,324,906 were obligated at the time of the award. Army Contracting Command, Natick, Massachusetts, is the contracting activity.
Sep 2019: Ology Bioservices Inc.,* Alachua, Florida, was awarded a $10,870,944 modification (P00054) to contract W911QY-13-C-0010 to establish, commission and support an agile and flexible advanced development and manufacturing capability. Work will be performed in Alachua, Florida, with an estimated completion date of March 19, 2023. Fiscal 2020 research, development, test and evaluation funds in the amount of $7,845,964 were obligated at the time of the award. U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity.
Dec 2019: Ology Bioservices Inc., Alachua, Florida, was awarded an $8,553,208 modification (P00058) to contract W911QY-13-C-0010 to support the Medical Countermeasures Advanced Development and Manufacturing Center Sustainment by maintaining the Advanced Development and Manufacturing facility in a state of readiness and operational availability to develop, test and/or manufacture medical countermeasures. Work will be performed in Alachua, Florida, with an estimated completion date of March 19, 2023. Fiscal 2021 research, development, test and evaluation, defense-wide funds in the amount of $8,553,208 were obligated at the time of the award. U.S. Army Contracting Command, Aberdeen Proving Ground, Natick Division, Natick, Massachusetts, is the contracting activity.
Status
(Closed)
Last Modified 12/31/25
Period of Performance
3/20/13
Start Date
3/20/23
Current End Date
10/31/23
Potential End Date
Obligations and Backlog
$276.8M
Total Obligated
$282.3M
Current Award
$366.3M
Potential Award
$5.5M
Funded Backlog
$89.5M
Total Backlog
Award Hierarchy
Definitive Contract
W911QY13C0010
Subcontracts
Activity Timeline
Opportunity Lifecycle
Procurement history for W911QY13C0010
Transaction History
Modifications to W911QY13C0010
People
Suggested agency contacts for W911QY13C0010
Competition
Number of Bidders
2
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Performance Based Acquisition
Yes
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Defense Program
None
DoD Claimant Code
Medical And Dental Supplies And Equipment
IT Commercial Item Category
Not Applicable
Awardee UEI
GC2RFAZK8G64
Awardee CAGE
3GQS9
Agency Detail
Awarding Office
W911SR W6QK ACC-APG
Funding Office
W56XNH
Created By
brian.e.mazen.civ@army.mil
Last Modified By
fpdsadmin
Approved By
brian.e.mazen.civ@army.mil
Legislative
Legislative Mandates
Materials, Supplies, Articles & Equipment
Performance District
FL-03
Senators
Marco Rubio
Rick Scott
Rick Scott
Representative
Katherine Cammack
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Research, Development, Test, and Evaluation, Defense-Wide (097-0400) | Department of Defense-Military | Research and development contracts (25.5) | $19,910,440 | 89% |
| Research, Development, Test, and Evaluation, Defense-Wide (097-0400) | Department of Defense-Military | Other services from non-Federal sources (25.2) | $2,464,858 | 11% |
Modified: 12/31/25